Everest Organics Limited

Overview

Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).

API / Drug Master Files

Everest Organics Limited holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• VONOPRAZAN FUMARATEActive2024-10-16
• OMEPRAZOLE MAGNESIUM USPActive2024-06-19
• OMEPRAZOLE SULPHIDEActive2023-08-16
• BEMPEDOIC ACIDActive2023-01-30
• OMEPRAZOLE USPActive2022-05-30
• PANTOPRAZOLE SODIUM USPActive2022-02-07
• ESOMEPRAZOLE MAGNESIUM TRIHYDRATEActive2018-12-20
• OMEPRAZOLE CHLORO COMPOUNDActive2015-01-22

FDA compliance signals